Biological Effects of Intravenous Vitamin C on Neutrophil Extracellular Traps and the Endothelial Glycocalyx in Patients with Sepsis-Induced ARDS.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
21 Oct 2022
Historique:
received: 02 08 2022
revised: 15 09 2022
accepted: 30 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

(1) Background: The disease-modifying mechanisms of high-dose intravenous vitamin C (HDIVC) in sepsis induced acute respiratory distress syndrome (ARDS) is unclear. (2) Methods: We performed a post hoc study of plasma biomarkers from subjects enrolled in the randomized placebo-controlled trial CITRIS-ALI. We explored the effects of HDIVC on cell-free DNA (cfDNA) and syndecan-1, surrogates for neutrophil extracellular trap (NET) formation and degradation of the endothelial glycocalyx, respectively. (3) Results: In 167 study subjects, baseline cfDNA levels in HDIVC (84 subjects) and placebo (83 subjects) were 2.18 ng/µL (SD 4.20 ng/µL) and 2.65 ng/µL (SD 3.87 ng/µL), respectively,

Identifiants

pubmed: 36297099
pii: nu14204415
doi: 10.3390/nu14204415
pmc: PMC9610384
pii:
doi:

Substances chimiques

Syndecan-1 0
Ascorbic Acid PQ6CK8PD0R
Vitamins 0
Biomarkers 0
Cell-Free Nucleic Acids 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Heart Lung and Blood Institute
ID : UM1HL116885

Références

PLoS One. 2014 Nov 13;9(11):e111755
pubmed: 25392950
Am J Physiol Lung Cell Mol Physiol. 2012 Jul 1;303(1):L20-32
pubmed: 22523283
Crit Care Med. 2011 Jun;39(6):1454-60
pubmed: 21358394
Nutrients. 2013 Aug 09;5(8):3131-51
pubmed: 23939536
Shock. 2008 Dec;30(6):623-7
pubmed: 18497712
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
J Crit Care. 2018 Feb;43:48-53
pubmed: 28843664
J Intensive Care. 2020 Apr 10;8:25
pubmed: 32308985
Crit Care. 2019 Jan 17;23(1):16
pubmed: 30654825
Chest. 2018 Aug;154(2):317-325
pubmed: 29555594
J Transl Med. 2014 Jan 31;12:32
pubmed: 24484547
Crit Care. 2012 Aug 13;16(4):R151
pubmed: 22889177
Clin Chem. 2008 Jun;54(6):1000-7
pubmed: 18420731
Pflugers Arch. 2007 Jun;454(3):345-59
pubmed: 17256154
Nat Med. 2012 Aug;18(8):1217-23
pubmed: 22820644
J Clin Invest. 2016 May 2;126(5):1612-20
pubmed: 27135878
J Thromb Haemost. 2019 Feb;17(2):283-294
pubmed: 30582882
Clin Biochem. 2016 Jul;49(10-11):768-76
pubmed: 26953518
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
JAMA. 2020 Feb 25;323(8):792-793
pubmed: 32096845
J Clin Invest. 2012 Aug;122(8):2731-40
pubmed: 22850883
Shock. 2017 Feb;47(2):132-139
pubmed: 27617671
Eur J Immunol. 2019 Feb;49(2):221-227
pubmed: 30629284
J Intern Med. 2018 Oct;284(4):418-426
pubmed: 29687943
N Engl J Med. 2005 Oct 20;353(16):1685-93
pubmed: 16236739
Ann Intensive Care. 2017 Oct 6;7(1):102
pubmed: 28986821
FEBS Lett. 2010 Jul 16;584(14):3193-7
pubmed: 20541553
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415887
JAMA. 2019 Oct 1;322(13):1261-1270
pubmed: 31573637
Stat Med. 2013 Jan 15;32(1):67-80
pubmed: 22833304
J Crit Care. 2018 Oct;47:93-98
pubmed: 29936329
Sci Rep. 2016 Nov 16;6:37252
pubmed: 27849031
Curr Opin Hematol. 2017 Jan;24(1):66-71
pubmed: 27820735
J Cell Biol. 2007 Jan 15;176(2):231-41
pubmed: 17210947

Auteurs

Xian Qiao (X)

Division of Pulmonary Disease & Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA.

Markos G Kashiouris (MG)

Division of Pulmonary Disease & Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA.

Michael L'Heureux (M)

Division of Pulmonary Disease & Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA.

Bernard J Fisher (BJ)

Division of Pulmonary Disease & Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA.

Stefan W Leichtle (SW)

Division of Acute Care Surgical Services, Virginia Commonwealth University, Richmond, VA 23219, USA.

Jonathon D Truwit (JD)

Division of Pulmonary Disease & Critical Care Medicine, Froedtert and the Medical College of Wisconsin, Aurora St. Luke's Medical Center, Milwaukee, WI 53215, USA.

Rahul Nanchal (R)

Division of Pulmonary Disease & Critical Care Medicine, Froedtert and the Medical College of Wisconsin, Aurora St. Luke's Medical Center, Milwaukee, WI 53215, USA.

Robert Duncan Hite (RD)

Division of Pulmonary Disease & Critical Care Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.

Peter E Morris (PE)

Division of Pulmonary Disease & Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Greg S Martin (GS)

Division of Pulmonary Disease & Critical Care Medicine, Emory University, Atlanta, GA 30322, USA.

Jonathan Sevransky (J)

Division of Pulmonary Disease & Critical Care Medicine, Emory University, Atlanta, GA 30322, USA.

Alpha A Fowler (AA)

Division of Pulmonary Disease & Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH